AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35676803 — intervention group
Group type: COMPARATOR
Intervention: Sacubitril/valsartan
Number of subjects: 12
Study 35676803 — intervention group
Group type: COMPARATOR
Intervention: Sitagliptin
Number of subjects: 12
Study 35676803 — intervention group
Group type: COMPARATOR
Intervention: Sacubitril/valsartan + Sitagliptin
Number of subjects: 12
Study 35676803 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 12
Study 35676803 — intervention group
Group type: COMPARATOR
Intervention: Valsartan alone
Number of subjects: 12
Study 33469832 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibegron 75 mg once daily
Number of subjects: 1463
Study 33469832 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1463
Study 33469832 — intervention group
Group type: COMPARATOR
Intervention: Tolterodine 4 mg extended release
Number of subjects: 1463
Study 32179445 — intervention group
Group type: EXPERIMENTAL
Intervention: Care pathway including QoL-profiles consisting of 13 QoL scales plus specific therapeutic recommendations forwarded to the patient's coordinating practitioner (CP)
Number of subjects: 220
Study 32179445 — intervention group
Group type: COMPARATOR
Intervention: Standard postoperative care adhering to the German national guideline for colorectal cancer (control)
Number of subjects: 220
Study 34750334 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure control with SBP < 120 mmHg
Number of subjects: 0
Study 34750334 — intervention group
Group type: COMPARATOR
Intervention: Conservative blood pressure control as per JNC-8 guidelines
Number of subjects: 0
Study 34081749 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood non-victims of emotional abuse
Number of subjects: 1929
Study 34081749 — intervention group
Group type: EXPERIMENTAL
Intervention: Victims of mild emotional abuse
Number of subjects: 1929
Study 34081749 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood non-victims of physical abuse
Number of subjects: 1929
Study 34081749 — intervention group
Group type: EXPERIMENTAL
Intervention: Victims of mild physical abuse
Number of subjects: 1929
Study 34081749 — intervention group
Group type: COMPARATOR
Intervention: Childhood experiences of severe emotional abuse
Number of subjects: 1929
Study 34081749 — intervention group
Group type: COMPARATOR
Intervention: Childhood experiences of severe physical abuse
Number of subjects: 1929
Study 34353994 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative immunonutrition plus a normal diet
Number of subjects: 176
Study 33427772 — intervention group
Group type: EXPERIMENTAL
Intervention: HA hydrogel
Number of subjects: 192
Study 33427772 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 192
Study 32009091 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenalidomide plus dexamethasone (15 mg in cycle 1, 25 mg in cycles 2-6, dexamethasone 20 mg once a week)
Number of subjects: 5
Study 32009091 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenalidomide plus dexamethasone
Number of subjects: 5
Study 35584433 — intervention group
Group type: EXPERIMENTAL
Intervention: 16-week aerobic and resistance training
Number of subjects: 128
Study 35584433 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 128
Study 35584433 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline in-trial GFR
Number of subjects: 128
Study 35584433 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline ABI
Number of subjects: 128
Study 35584433 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower ABI
Number of subjects: 128
Study 35584433 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher systolic blood pressure
Number of subjects: 128
Study 33453514 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise therapy (ET) 3 times/week for 12 weeks
Number of subjects: 60
Study 33453514 — intervention group
Group type: COMPARATOR
Intervention: No-attention control group (CG)
Number of subjects: 60
Study 33453514 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise therapy (ET)
Number of subjects: 60
Study 35775544 — intervention group
Group type: EXPERIMENTAL
Intervention: Community lay counselors, self-help groups (SHGs), and trained frontline health workers for 2 years
Number of subjects: 0
Study 35775544 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 34335819 — intervention group
Group type: EXPERIMENTAL
Intervention: Garlic tablets (400 mg)
Number of subjects: 60
Study 34335819 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 60
Study 35386698 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted increased BMI
Number of subjects: 14802
Study 35386698 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-6 signaling
Number of subjects: 14802
Study 35386698 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher BMI
Number of subjects: 14802
Study 35386698 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-6 signaling after adjusting for BMI
Number of subjects: 14802
Study 35386698 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher BMI after adjustment for IL-6 signaling
Number of subjects: 14802
Study 35386698 — intervention group
Group type: EXPERIMENTAL
Intervention: Effect of BMI on MS mediated by IL-6 signaling
Number of subjects: 14802
Study 34768722 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel influenza vaccine with continuous monitoring using a wearable sensor.
Number of subjects: 116
Study 34768722 — intervention group
Group type: EXPERIMENTAL
Intervention: Random Forest classifier model applied to physiological data.
Number of subjects: 116
Study 34768722 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiological data from the first and second day.
Number of subjects: 116
Study 32124136 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal BMD
Number of subjects: 1860
Study 32124136 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopenia
Number of subjects: 1860
Study 32124136 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteoporosis
Number of subjects: 1860
Study 32124136 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisphosphonate use
Number of subjects: 1860
Study 34323455 — intervention group
Group type: EXPERIMENTAL
Intervention: Transforaminal Epidural Steroid Injection (TFESI)
Number of subjects: 302
Study 35060097 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle Shortening Manoeuvre (MSM)
Number of subjects: 24
Study 35060097 — intervention group
Group type: COMPARATOR
Intervention: Simple traction
Number of subjects: 24
Study 33752390 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 mg once daily)
Number of subjects: 3730
Study 33752390 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3730
Study 35947150 — intervention group
Group type: EXPERIMENTAL
Intervention: Tympanoplasty with mastoidectomy (G1 group)
Number of subjects: 51
Study 35947150 — intervention group
Group type: COMPARATOR
Intervention: Tympanoplasty only (G2 group)
Number of subjects: 51
Study 33634738 — intervention group
Group type: EXPERIMENTAL
Intervention: SIT (sprint interval training)
Number of subjects: 66
Study 33634738 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT (high-intensity interval training)
Number of subjects: 66
Study 33634738 — intervention group
Group type: EXPERIMENTAL
Intervention: MICT (moderate-intensity continuous training)
Number of subjects: 66
Study 33634738 — intervention group
Group type: COMPARATOR
Intervention: CON (non-exercise control)
Number of subjects: 66
Study 33634738 — intervention group
Group type: EXPERIMENTAL
Intervention: All training groups
Number of subjects: 66
Study 32035124 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation strategies including patient coaching, automated texting, peer phone support, academic detailing and audit and feedback for the patient's clinician.
Number of subjects: 0
Study 35489367 — intervention group
Group type: EXPERIMENTAL
Intervention: ENO Breathe programme
Number of subjects: 150
Study 35489367 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 150
Study 34941126 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-disciplinary intervention program
Number of subjects: 0
Study 34941126 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 33535811 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental COVID-19 vaccine
Number of subjects: 0
Study 33535811 — intervention group
Group type: COMPARATOR
Intervention: Active comparator vaccine
Number of subjects: 0
Study 32097103 — intervention group
Group type: EXPERIMENTAL
Intervention: Agility training performed in the form of competitive exercising (experimental group)
Number of subjects: 22
Study 32097103 — intervention group
Group type: COMPARATOR
Intervention: Standard agility training (control group)
Number of subjects: 22
Study 33865923 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise without dyslipidemia (EG/n = 11)
Number of subjects: 70
Study 33865923 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise with dyslipidemia (EGD/n = 24)
Number of subjects: 70
Study 33865923 — intervention group
Group type: COMPARATOR
Intervention: Control with dyslipidemia (CGD/n = 22)
Number of subjects: 70
Study 33865923 — intervention group
Group type: COMPARATOR
Intervention: Control without dyslipidemia (CG/n = 13)
Number of subjects: 70
Study 34210242 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-supplementation group (n = 27): 50000 IU vitamin D soft gel weekly + 250 mg magnesium tablet daily
Number of subjects: 108
Study 34210242 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D group (n = 27): 50000 IU vitamin D soft gel weekly + magnesium placebo daily
Number of subjects: 108
Study 34210242 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium group (n = 27): vitamin D placebo weekly + 250 mg magnesium tablet daily
Number of subjects: 108
Study 34210242 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 27): vitamin D placebo weekly + magnesium placebo daily
Number of subjects: 108
Study 34274608 — intervention group
Group type: EXPERIMENTAL
Intervention: PERF-FIT Moving cans balance score
Number of subjects: 74
Study 34274608 — intervention group
Group type: EXPERIMENTAL
Intervention: PERF-FIT static balance score
Number of subjects: 74
Study 34274608 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance Sensory score
Number of subjects: 74
Study 33301040 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdisciplinary pain management program for chronic musculoskeletal pain
Number of subjects: 103
Study 33019856 — intervention group
Group type: EXPERIMENTAL
Intervention: Testing of symptomatic and asymptomatic patients in building zero
Number of subjects: 65
Study 33019856 — intervention group
Group type: EXPERIMENTAL
Intervention: Testing of asymptomatic patients in building zero
Number of subjects: 65
Study 33019856 — intervention group
Group type: COMPARATOR
Intervention: Testing of randomly selected asymptomatic patients from the rest of the hospital
Number of subjects: 65
Study 33657442 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic drink (0.6 g/kg)
Number of subjects: 84
Study 33657442 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic drink (0.3 g/kg)
Number of subjects: 84
Study 33657442 — intervention group
Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 84
Study 32893106 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsal nerve relocation (DNR)
Number of subjects: 47
Study 32893106 — intervention group
Group type: COMPARATOR
Intervention: Dorsal neurectomy (DN)
Number of subjects: 47
Study 35585483 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexmedetomidine (DEX)
Number of subjects: 60
Study 35585483 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Control)
Number of subjects: 60
Study 33793960 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous EEG (cEEG)
Number of subjects: 366
Study 33793960 — intervention group
Group type: COMPARATOR
Intervention: Routine EEG (rEEG)
Number of subjects: 366
Study 33793960 — intervention group
Group type: EXPERIMENTAL
Intervention: cEEG
Number of subjects: 366
Study 33793960 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of acute hospitalisation
Number of subjects: 366
Study 33130217 — intervention group
Group type: EXPERIMENTAL
Intervention: pm‐Pac (230 mg/m2) plus cisplatin (70 mg/m2)
Number of subjects: 448
Study 33130217 — intervention group
Group type: COMPARATOR
Intervention: sb‐Pac (175 mg/m2) plus cisplatin (70 mg/m2)
Number of subjects: 448
Study 32652516 — intervention group
Group type: EXPERIMENTAL
Intervention: PCR diet (30% calorie and 80% protein reduction)
Number of subjects: 35
Study 32652516 — intervention group
Group type: COMPARATOR
Intervention: Control group (without restrictions)
Number of subjects: 35
Study 33844408 — intervention group
Group type: EXPERIMENTAL
Intervention: Low FODMAP dietary advice
Number of subjects: 59
Study 33844408 — intervention group
Group type: COMPARATOR
Intervention: Standard dietary advice
Number of subjects: 59
Study 32234584 — intervention group
Group type: EXPERIMENTAL
Intervention: Protect Your Family intervention
Number of subjects: 1475
Study 32234584 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 1475
Study 34761392 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-assessment using the study roadmap tool
Number of subjects: 30
Study 34761392 — intervention group
Group type: COMPARATOR
Intervention: Instructor supervision only (Control)
Number of subjects: 30
Study 32024402 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous microwave ablation (PMWA)
Number of subjects: 133
Study 32024402 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-guided radiofrequency ablation (USgRFA)
Number of subjects: 133
Study 32024402 — intervention group
Group type: EXPERIMENTAL
Intervention: PMWA
Number of subjects: 133
Study 32024402 — intervention group
Group type: COMPARATOR
Intervention: USgRFA
Number of subjects: 133
Study 34501248 — intervention group
Group type: EXPERIMENTAL
Intervention: sCXL (standard Dresden protocol) with 30 min pre-soaking and 3 mW/cm2 UVA irradiation for 30 min
Number of subjects: 41
Study 34501248 — intervention group
Group type: EXPERIMENTAL
Intervention: aCFXL (accelerated custom-fast protocol) with 10 min pre-soaking and 1.8 ± 0.9 mW/cm2 UVA irradiation for 10 min ± 1.5 min
Number of subjects: 41
Study 34501248 — intervention group
Group type: COMPARATOR
Intervention: Comparison between sCXL and aCFXL
Number of subjects: 41
Study 36037146 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term drainage (drain removed 24 hours after surgery)
Number of subjects: 88
Study 36037146 — intervention group
Group type: COMPARATOR
Intervention: Long-term drainage (drain removed 5 days after surgery)
Number of subjects: 88
Study 36037146 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term drainage
Number of subjects: 88
Study 35585525 — intervention group
Group type: EXPERIMENTAL
Intervention: PRISM intervention (resilience-coaching program with four scripted coaching sessions targeting skills in stress-management, goal setting, cognitive-restructuring, and meaning-making)
Number of subjects: 90
Study 35585525 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 90
Study 34663421 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical vertebral mobilization technique and exercise
Number of subjects: 28
Study 34663421 — intervention group
Group type: COMPARATOR
Intervention: Minimal superficial circular pressure on the skin and exercise
Number of subjects: 28
Study 32624365 — intervention group
Group type: EXPERIMENTAL
Intervention: self-locking stand-alone cage
Number of subjects: 120
Study 32624365 — intervention group
Group type: COMPARATOR
Intervention: plate group
Number of subjects: 120
Study 35063352 — intervention group
Group type: EXPERIMENTAL
Intervention: Convolutional Neural Network (CNN) model based on transfer learning using chest radiographs (CRs)
Number of subjects: 3972
Study 34919414 — intervention group
Group type: EXPERIMENTAL
Intervention: Animal-assisted interactions
Number of subjects: 0
Study 34919414 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 35766028 — intervention group
Group type: EXPERIMENTAL
Intervention: Tafamidis
Number of subjects: 78
Study 33043978 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary Medical Male Circumcision (VMMC)
Number of subjects: 3916
Study 33043978 — intervention group
Group type: COMPARATOR
Intervention: Uncircumcised men (Control)
Number of subjects: 3916
Study 35633401 — intervention group
Group type: EXPERIMENTAL
Intervention: High power (HP) laser lithotripsy settings
Number of subjects: 120
Study 35633401 — intervention group
Group type: COMPARATOR
Intervention: Low power (LP) laser lithotripsy settings
Number of subjects: 120
Study 34636753 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine with dexmedetomidine (group RD)
Number of subjects: 60
Study 34636753 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine with normal saline (group R)
Number of subjects: 60
Study 35388496 — intervention group
Group type: EXPERIMENTAL
Intervention: Metacognitive training (MCT)
Number of subjects: 46
Study 35388496 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 46
Study 34678981 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevelamer (2400 mg daily)
Number of subjects: 40
Study 34678981 — intervention group
Group type: COMPARATOR
Intervention: Calcium carbonate (1500 mg daily)
Number of subjects: 40
Study 32821251 — intervention group
Group type: EXPERIMENTAL
Intervention: Recollection-based occupational therapy program (24 sessions, 5 times per week for 1 hour each)
Number of subjects: 0
Study 32821251 — intervention group
Group type: COMPARATOR
Intervention: Regular activities offered by existing facilities (Control group)
Number of subjects: 0
Study 34487834 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants in the exercise RCT
Number of subjects: 914
Study 34487834 — intervention group
Group type: COMPARATOR
Intervention: Non-participants and non-invited women
Number of subjects: 914
Study 34981234 — intervention group
Group type: EXPERIMENTAL
Intervention: Blocked training schedule
Number of subjects: 44
Study 34981234 — intervention group
Group type: EXPERIMENTAL
Intervention: Random training schedule
Number of subjects: 44
Study 34981234 — intervention group
Group type: COMPARATOR
Intervention: Control group (no additional training)
Number of subjects: 44
Study 34131002 — intervention group
Group type: EXPERIMENTAL
Intervention: Prexasertib at 70 mg/m2 i.v. with olaparib at 100 mg by mouth twice daily
Number of subjects: 29
Study 34131002 — intervention group
Group type: COMPARATOR
Intervention: Olaparib alone (7-day lead-in)
Number of subjects: 29
Study 32437393 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT) using commercially‐available anaerobic cultivated human intestinal microbiota (ACHIM)
Number of subjects: 10
Study 32437393 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 36322184 — intervention group
Group type: EXPERIMENTAL
Intervention: High BAC (0.08%)
Number of subjects: 17
Study 36322184 — intervention group
Group type: EXPERIMENTAL
Intervention: Low BAC (0.05%)
Number of subjects: 17
Study 36322184 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 33621007 — intervention group
Group type: EXPERIMENTAL
Intervention: Monopolar TUR (M-TURBT)
Number of subjects: 80
Study 33621007 — intervention group
Group type: COMPARATOR
Intervention: Bipolar TUR (B-TURBT)
Number of subjects: 80
Study 35927705 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual cognitive-behavioral sexual counseling (8 sessions of 90 minutes)
Number of subjects: 80
Study 35927705 — intervention group
Group type: COMPARATOR
Intervention: Routine prenatal care
Number of subjects: 80
Study 32763538 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS), 20 treatments over four weeks
Number of subjects: 153
Study 35671327 — intervention group
Group type: EXPERIMENTAL
Intervention: SOC+RT (Standard of Care plus Radiotherapy)
Number of subjects: 1939
Study 35671327 — intervention group
Group type: COMPARATOR
Intervention: SOC (Standard of Care)
Number of subjects: 1939
Study 33199796 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) for 15 weeks
Number of subjects: 55
Study 33199796 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 55
Study 33199796 — intervention group
Group type: COMPARATOR
Intervention: Control (sedentary)
Number of subjects: 55
Study 36459264 — intervention group
Group type: EXPERIMENTAL
Intervention: CHARISMA intervention to increase women's agency to use oral pre‐exposure prophylaxis (PrEP) safely and consistently.
Number of subjects: 0
Study 36459264 — intervention group
Group type: EXPERIMENTAL
Intervention: CHARISMA intervention
Number of subjects: 0
Study 33892086 — intervention group
Group type: EXPERIMENTAL
Intervention: Effective Dose 50 (ED50) method for depression
Number of subjects: 1122
Study 33892086 — intervention group
Group type: EXPERIMENTAL
Intervention: PHQ‐9
Number of subjects: 1122
Study 33892086 — intervention group
Group type: EXPERIMENTAL
Intervention: GAD‐7
Number of subjects: 1122
Study 32410485 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine intake (baseline)
Number of subjects: 9694
Study 35609409 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard pemetrexed maintenance therapy
Number of subjects: 365
Study 35609409 — intervention group
Group type: COMPARATOR
Intervention: Durvalumab
Number of subjects: 365
Study 35018526 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiritually sensitive logotherapy intervention (twelve-session group programme)
Number of subjects: 60
Study 35018526 — intervention group
Group type: COMPARATOR
Intervention: Control group (secular control interventions)
Number of subjects: 60
Study 33760859 — intervention group
Group type: EXPERIMENTAL
Intervention: VR training with augmented multisensory cues
Number of subjects: 3
Study 33760859 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional VR training
Number of subjects: 3
Study 33760859 — intervention group
Group type: COMPARATOR
Intervention: Control group (real tyre change only)
Number of subjects: 3
Study 33760859 — intervention group
Group type: EXPERIMENTAL
Intervention: All VR training paradigms
Number of subjects: 3
Study 33760859 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented multisensory cues
Number of subjects: 3
Study 32715995 — intervention group
Group type: EXPERIMENTAL
Intervention: TAVI
Number of subjects: 1660
Study 32715995 — intervention group
Group type: EXPERIMENTAL
Intervention: SAVR
Number of subjects: 1660